Funding for this research was provided by:
Evelyn Trust (EW9035322)
Diabetes UK (11/0004241)
Wellbeing of Women (RG1644)
Medical Research Council (UD99999906, G0800783, MC_UU_12015/, G1001995)
Fifth Framework Programme (QLK4-1999-01422)
Newlife Foundation for Disabled Children (07/20)
World Cancer Research Fund (2004/03)
Mothercare Charitable Foundation (RG54608)
Text and Data Mining valid from 2018-08-29
Received: 21 June 2018
Accepted: 13 August 2018
First Online: 29 August 2018
Ethics approval and consent to participate
: The Cambridge Baby Growth Study was approved by the Local Ethics Committee, Addenbrooke’s Hospital, Cambridge, U.K. (LREC 00/325) and was conducted according to the principles expressed in the Declaration of Helsinki. Written informed consent, including that for anonymised genetic testing, was obtained from the parents, including consent for inclusion of their infants in the study.
: The aim of the study was carefully explained to all of the participants, who provided their written informed consent including that for anonymised genetic testing, for inclusion of their infants in the study and for publication.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.